Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:06 AM
Ignite Modification Date:
2025-12-25 @ 4:06 AM
NCT ID:
NCT01079520
Eligibility Criteria:
Inclusion Criteria:
* Histology-proven non-small cell lung cancer
* N2 or N3 lymph node invasion is suspected based on chest CT or PET/CT scans (at least one of three criteria) : 1) enlarged (1cm or more in short axis diameter) mediastinal lymph node(s), 2) FDG uptake in the mediastinal lymph node(s), or 3) FDG uptake in N1 node(s)
* The patient is otherwise considered a candidate for a surgical treatment with the intention to cure
Exclusion Criteria:
* Distant metastasis
* Inoperable T4 disease
* Confirmed supraclavicular lymph node metastasis
* Former therapy (chemotherapy or radiotherapy or surgery) for lung cancer
* Contraindications for bronchoscopy
* Uncorrected coagulopathy
* Concurrent other malignancies
* Suspicious mediastinal lymph node metastasis which are not accessible by EBUS-TBNA or mediastinoscopy (i.e. paraaortic, aortopulmonary window, or paraesophageal lymph nodes)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01079520
Study Brief:
Protocol Section:
NCT01079520